Mirati Therapeutics, Inc.

Assenagon Asset Management S.A.

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/6/2023

Shares

1,825,678

Value ($000)

79,527

Weight

0.3%

2020 Q2 - 2023 Q3 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/6/2023	79,527	0.3%	1,825,678	9/30/2023
2023 Q2	7/25/2023	29,223	0.1%	808,820	6/30/2023
2023 Q1	4/18/2023	9,517	0.0%	255,960	3/31/2023
2022 Q4	1/12/2023	7,693	0.0%	169,785	12/31/2022
2022 Q3	10/27/2022	13,509	0.1%	193,428	9/30/2022
2022 Q2	7/27/2022	57,191	0.2%	851,950	6/30/2022
2022 Q1	4/25/2022	4,392	0.0%	53,422	3/31/2022
2021 Q4	2/1/2022	13,519	0.1%	92,160	12/31/2021
2021 Q3	10/19/2021	64,148	0.3%	362,600	9/30/2021
2021 Q2	7/15/2021	58,726	0.3%	363,559	6/30/2021
2021 Q1	4/26/2021	49,940	0.3%	291,538	3/31/2021
2020 Q4	2/1/2021	10,114	0.1%	46,050	12/31/2020
2020 Q3	10/7/2020	21,387	0.2%	128,800	9/30/2020
2020 Q2	7/21/2020	11,574	0.1%	101,374	6/30/2020